TAM
TECH icon

Tucker Asset Management’s Bio-Techne TECH Stock Holding History

Tucker Asset Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-80
Closed -$8.66K – 698
2022
Q1 		$8.66K Hold
80
– – ﹤0.01% 253
2021
Q4 		$10.2K Buy
+80
New +$9.81K ﹤0.01% 208

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Tucker Asset Management's TECH Position: Q2 2022 in Review

Tucker Asset Management sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 80 shares — an estimated $8.66K sold.

Tucker Asset Management first reported a position in TECH in Q4 2021 and held it in 2 quarters. The position peaked at $10.2K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Tucker Asset Management reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Tucker Asset Management sold 80 Bio-Techne shares in Q2 2022, an estimated $8.66K.
  • Tucker Asset Management first reported a position in Bio-Techne in Q4 2021 and held it in 2 quarters.
  • Tucker Asset Management's Bio-Techne position peaked at $10.2K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Tucker Asset Management's 13F filing for Q2 2022, filed 11 May 2023.